Sarepta Therapeutics | SRPT - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amgen USD 9.57B 1.08B 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Capricor Therapeutics USD 59K 0 2025-12
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Insmed USD 140.86M 75.6M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Moderna USD 184M 862M 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12